Last edition
News about "Acquisition news"
Emcure's Marcan Pharma to Acquire Remaining Stake in Mantra Pharma
Emcure Pharmaceuticals' subsidiary Marcan Pharmaceuticals has signed agreements to acquire the remaining Class E Special Shares of Canada's Mantra Pharma, making the company a wholly owned subsidiary.
Acquisition News | 06/07/2026 | By News Bureau
Jagsonpal Pharmaceuticals to Acquire 85 Percent Stake in Aequitas Healthcare for INR 20.8 Crore
Aeguitas Healthcare’s acquisition marks Jagsonpal's entry into the hospital pharmaceutical segment, strengthening its omnichannel healthcare strategy and expanding its institutional market presence.
Acquisition News | 01/07/2026 | By News Bureau
Aurobindo Pharma USA Completes Acquisition of Lannett Company
Aurobindo Pharma USA has completed the acquisition of Lannett Company after securing approval from the US Federal Trade Commission. Effective June 29, 2026, Lannett will operate as Lannett Company LLC, with the combined entity aiming to strengthen the supply of essential medicines and enhance value for patients and customers.
Acquisition News | 30/06/2026 | By News Bureau
Neurocrine Biosciences to Acquire Soleno Therapeutics in USD 2.9 Billion Deal
The acquisition brings first-in-class Prader-Willi syndrome therapy VYKAT XR into Neurocrine’s portfolio, strengthening its position in endocrinology and rare diseases.
Acquisition News | 07/04/2026 | By News Bureau | 117
Zuellig Pharma has acquired rights to Cialis from Eli Lilly and Company in Hong Kong, Macau and South Korea, expanding its ownership of the men’s health drug across 11 Asian markets.
Acquisition News | 16/03/2026 | By News Bureau | 423
Sanofi Completes Acquisition of Dynavax, Expands Adult Vaccine Portfolio with HEPLISAV-B
Sanofi has finalised its acquisition of Dynavax, adding hepatitis B vaccine HEPLISAV-B and a shingles vaccine candidate to strengthen its global adult immunisation business.
Acquisition News | 12/02/2026 | By News Bureau | 286
Sobi has acquired Arthrosi Therapeutics, adding phase III gout candidate pozdeutinurad (AR882) to its portfolio, with trial results expected in 2026.
Acquisition News | 11/02/2026 | By News Bureau | 195
Lilly’s acquisition of Orna Therapeutics aims to accelerate development of in vivo CAR-T therapies powered by engineered circular RNA and advanced lipid nanoparticle delivery platforms.
Acquisition News | 10/02/2026 | By News Bureau | 237
Illumina has completed its USD 350 million acquisition of SomaLogic, strengthening its multiomics portfolio and expanding large-scale proteomics capabilities to accelerate drug discovery and improve patient outcomes.
Acquisition News | 02/02/2026 | By News Bureau | 974
GSK will acquire RAPT Therapeutics for USD 2.2 billion, adding phase IIb anti-IgE antibody ozureprubart to its pipeline, targeting long-acting protection for patients with severe food allergies.
Acquisition News | 20/01/2026 | By News Bureau | 238
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy